117th Congress · HOUSE BILLBILL

H.R. 7640 — To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").

“To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").”

Health

Introduced May 3, 2022

Last action May 3, 2022

Pipeline · Bill → Law

Step 1

Introduced

May 3, 2022

Step 2

Referred

May 3, 2022

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 1 sectionsIntroduced in House

Timeline · 2 actions

May 3, 2022

Introduced in House

May 3, 2022

Referred to the House Committee on Energy and Commerce.